RENALYTIX AI PLC-ADR (RNLX) Stock Price, Quote, News and Overview
NASDAQ:RNLX - Nasdaq - US75973T1016 - ADR - Currency: USD
RNLX Quote, Performance and Key Statistics
0.2071
+0.01 (+5.66%)
The current stock price of RNLX is 0.2071 USD. In the past month the price decreased by -26.3%. In the past year, price decreased by -82.15%.
RNLX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.34 | 40.07B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.98 | 12.01B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.44B | ||
| CERT | CERTARA INC | 26.07 | 1.89B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 13.97 | 1.77B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.58B | ||
| SDGR | SCHRODINGER INC | N/A | 1.54B | ||
| PHR | PHREESIA INC | N/A | 1.38B | ||
| EVH | EVOLENT HEALTH INC - A | 13.62 | 1.05B | ||
| HSTM | HEALTHSTREAM INC | 49.74 | 999.02M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 989.63M | ||
| SLP | SIMULATIONS PLUS INC | 70.58 | 567.14M |
Related stock screener links
About RNLX
Company Profile
Renalytix Plc engages in the manufacturing of medical devices and equipment. The firm is engaged in a field of bioprognosis for kidney health. The firm has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. The company is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Company Info
RENALYTIX AI PLC-ADR
Finsgate, 5-7 Cranwood Street
London SOUTH GLAMORGAN CF64 2EZ GB
CEO: James McCullough
Employees: 102
Company Website: https://renalytix.com/
Phone: 442920710570
RENALYTIX AI PLC-ADR / RNLX FAQ
What is the stock price of RENALYTIX AI PLC-ADR today?
The current stock price of RNLX is 0.2071 USD. The price increased by 5.66% in the last trading session.
What is the ticker symbol for RENALYTIX AI PLC-ADR stock?
The exchange symbol of RENALYTIX AI PLC-ADR is RNLX and it is listed on the Nasdaq exchange.
On which exchange is RNLX stock listed?
RNLX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for RENALYTIX AI PLC-ADR stock?
5 analysts have analysed RNLX and the average price target is 2.67 USD. This implies a price increase of 1187.44% is expected in the next year compared to the current price of 0.2071. Check the RENALYTIX AI PLC-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is RENALYTIX AI PLC-ADR worth?
RENALYTIX AI PLC-ADR (RNLX) has a market capitalization of 17.18M USD. This makes RNLX a Nano Cap stock.
How many employees does RENALYTIX AI PLC-ADR have?
RENALYTIX AI PLC-ADR (RNLX) currently has 102 employees.
What are the support and resistance levels for RENALYTIX AI PLC-ADR (RNLX) stock?
RENALYTIX AI PLC-ADR (RNLX) has a resistance level at 0.24. Check the full technical report for a detailed analysis of RNLX support and resistance levels.
Is RENALYTIX AI PLC-ADR (RNLX) expected to grow?
The Revenue of RENALYTIX AI PLC-ADR (RNLX) is expected to grow by 39.85% in the next year. Check the estimates tab for more information on the RNLX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy RENALYTIX AI PLC-ADR (RNLX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RNLX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RNLX, evaluating the profitability, health, valuation and growth aspects
- RENALYTIX AI PLC-ADR (RNLX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RENALYTIX AI PLC-ADR (RNLX) Sales and EPS estimates to see what analysts future expectations are.
- RENALYTIX AI PLC-ADR (RNLX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RENALYTIX AI PLC-ADR (RNLX) Insider and Institutional Ownership to learn about the owners and their transactions.
- RENALYTIX AI PLC-ADR (RNLX) Stock Chart to make your own analysis
- RENALYTIX AI PLC-ADR (RNLX) Latest news and press-releases to stay up to date.
Does RENALYTIX AI PLC-ADR (RNLX) stock pay dividends?
RNLX does not pay a dividend.
When does RENALYTIX AI PLC-ADR (RNLX) report earnings?
RENALYTIX AI PLC-ADR (RNLX) will report earnings on 2024-10-29, after the market close.
What is the Price/Earnings (PE) ratio of RENALYTIX AI PLC-ADR (RNLX)?
RENALYTIX AI PLC-ADR (RNLX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).
RNLX Technical Analysis
RNLX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RNLX. RNLX has a bad profitability rating. Also its financial health evaluation is rather negative.
RNLX Financial Highlights
Over the last trailing twelve months RNLX reported a non-GAAP Earnings per Share(EPS) of -0.61. The EPS increased by 27.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -109.75% | ||
| ROE | -250.48% | ||
| Debt/Equity | 0.41 |
RNLX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to RNLX. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 59.3% and a revenue growth 39.85% for RNLX